These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 21270336)

  • 21. NLRP3 activation induces ASC-dependent programmed necrotic cell death, which leads to neutrophilic inflammation.
    Satoh T; Kambe N; Matsue H
    Cell Death Dis; 2013 May; 4(5):e644. PubMed ID: 23703389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of MF59 Adjuvant on Induction of Isotype-Switched IgG Antibodies and Protection after Immunization with T-Dependent Influenza Virus Vaccine in the Absence of CD4+ T Cells.
    Ko EJ; Lee YT; Kim KH; Jung YJ; Lee Y; Denning TL; Kang SM
    J Virol; 2016 Aug; 90(15):6976-6988. PubMed ID: 27226368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Nlrp3 inflammasome is critical for aluminium hydroxide-mediated IL-1beta secretion but dispensable for adjuvant activity.
    Franchi L; Núñez G
    Eur J Immunol; 2008 Aug; 38(8):2085-9. PubMed ID: 18624356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MF59-adjuvanted vaccines for seasonal and pandemic influenza prophylaxis.
    Banzhoff A; Pellegrini M; Del Giudice G; Fragapane E; Groth N; Podda A
    Influenza Other Respir Viruses; 2008 Nov; 2(6):243-9. PubMed ID: 19453401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammasome adaptor protein Apoptosis-associated speck-like protein containing CARD (ASC) is critical for the immune response and survival in west Nile virus encephalitis.
    Kumar M; Roe K; Orillo B; Muruve DA; Nerurkar VR; Gale M; Verma S
    J Virol; 2013 Apr; 87(7):3655-67. PubMed ID: 23302887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inactivated influenza vaccines: recent progress and implications for the elderly.
    Parodi V; de Florentiis D; Martini M; Ansaldi F
    Drugs Aging; 2011 Feb; 28(2):93-106. PubMed ID: 21275435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cutting edge: inflammasome activation by alum and alum's adjuvant effect are mediated by NLRP3.
    Li H; Willingham SB; Ting JP; Re F
    J Immunol; 2008 Jul; 181(1):17-21. PubMed ID: 18566365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MF59-adjuvanted influenza vaccine confers superior immunogenicity in adult subjects (18-60 years of age) with chronic diseases who are at risk of post-influenza complications.
    Baldo V; Baldovin T; Floreani A; Carraro AM; Trivello R;
    Vaccine; 2007 May; 25(20):3955-61. PubMed ID: 17383057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The adjuvant MF59 increases the immunogenicity and protective efficacy of subunit influenza vaccine in mice.
    Cataldo DM; Van Nest G
    Vaccine; 1997 Nov; 15(16):1710-5. PubMed ID: 9364672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dose ranging of adjuvant and antigen in a cell culture H5N1 influenza vaccine: safety and immunogenicity of a phase 1/2 clinical trial.
    Keitel W; Groth N; Lattanzi M; Praus M; Hilbert AK; Borkowski A; Tsai TF
    Vaccine; 2010 Jan; 28(3):840-8. PubMed ID: 19835829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effective Combination Adjuvants Engage Both TLR and Inflammasome Pathways To Promote Potent Adaptive Immune Responses.
    Seydoux E; Liang H; Dubois Cauwelaert N; Archer M; Rintala ND; Kramer R; Carter D; Fox CB; Orr MT
    J Immunol; 2018 Jul; 201(1):98-112. PubMed ID: 29769270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Purification and analysis of the interactions of caspase-1 and ASC for assembly of the inflammasome.
    Narayanan KB; Park HH
    Appl Biochem Biotechnol; 2015 Mar; 175(6):2883-94. PubMed ID: 25567507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cryopyrin activates the inflammasome in response to toxins and ATP.
    Mariathasan S; Weiss DS; Newton K; McBride J; O'Rourke K; Roose-Girma M; Lee WP; Weinrauch Y; Monack DM; Dixit VM
    Nature; 2006 Mar; 440(7081):228-32. PubMed ID: 16407890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Caspase-1 autoproteolysis is differentially required for NLRP1b and NLRP3 inflammasome function.
    Guey B; Bodnar M; Manié SN; Tardivel A; Petrilli V
    Proc Natl Acad Sci U S A; 2014 Dec; 111(48):17254-9. PubMed ID: 25404286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microbial pathogen-induced necrotic cell death mediated by the inflammasome components CIAS1/cryopyrin/NLRP3 and ASC.
    Willingham SB; Bergstralh DT; O'Connor W; Morrison AC; Taxman DJ; Duncan JA; Barnoy S; Venkatesan MM; Flavell RA; Deshmukh M; Hoffman HM; Ting JP
    Cell Host Microbe; 2007 Sep; 2(3):147-59. PubMed ID: 18005730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and immunogenicity of an MF59(®)-adjuvanted A/H5N1 pre-pandemic influenza vaccine in adults and the elderly.
    Vesikari T; Forstén A; Herbinger KH; Cioppa GD; Beygo J; Borkowski A; Groth N; Bennati M; von Sonnenburg F
    Vaccine; 2012 Feb; 30(7):1388-96. PubMed ID: 22192847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neisseria gonorrhoeae activates the proteinase cathepsin B to mediate the signaling activities of the NLRP3 and ASC-containing inflammasome.
    Duncan JA; Gao X; Huang MT; O'Connor BP; Thomas CE; Willingham SB; Bergstralh DT; Jarvis GA; Sparling PF; Ting JP
    J Immunol; 2009 May; 182(10):6460-9. PubMed ID: 19414800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunology and efficacy of MF59-adjuvanted vaccines.
    Ko EJ; Kang SM
    Hum Vaccin Immunother; 2018; 14(12):3041-3045. PubMed ID: 30015572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extrapolating theoretical efficacy of inactivated influenza A/H5N1 virus vaccine from human immunogenicity studies.
    Feldstein LR; Matrajt L; Elizabeth Halloran M; Keitel WA; Longini IM;
    Vaccine; 2016 Jul; 34(33):3796-802. PubMed ID: 27268778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MF59-adjuvanted and virosomal influenza vaccines for preventing influenza hospitalization in older people: comparative effectiveness using the Valencia health care information system.
    Puig-Barberà J; Natividad-Sancho A; Calabuig-Pérez J; Lluch-Rodrigo JA; Pastor-Villalba E; Martínez-Úbeda S; Pérez-Vilar S; Díez-Domingo J
    Vaccine; 2013 Aug; 31(37):3995-4002. PubMed ID: 23731629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.